derivation novel human ground state naive pluripotent stem cells 
mouse embryonic stem es cells isolated inner cell mass blastocysts can preserved vitro naive inner-cell-mass-like configuration providing exogenous stimulation leukaemia inhibitory factor lif small molecule inhibition erk1/erk2 gsk3 beta signalling termed 2i/lif conditions hallmarks naive pluripotency include driving oct4 also known pou5f1 transcription distal enhancer retaining pre-inactivation xchromosome state global reduction dna methylation h3k27me3 repressive chromatin mark deposition developmental regulatory gene promoters upon withdrawal 2i/lif naive mouse es cells can drift towards primed pluripotent state resembling post-implantation epiblast although human es cells share several molecular features naive mouse es cells also share variety epigenetic properties primed murine epiblast stemcells episcs include predominant use proximal enhancer element maintain oct4 expression pronounced tendency x chromosome inactivation female human es cells increase dna methylation prominent deposition h3k27me3 bivalent domain acquisition lineage regulatory genes feasibility establishing human ground state naive pluripotency vitro equivalent molecular functional features characterized mouse es cells remains defined establish defined conditions facilitate derivation genetically unmodified human naive pluripotent stem cells already established primed human es cells somatic cells induced pluripotent stemips cell reprogramming directly blastocysts novel naive pluripotent cells validated herein retain molecular characteristics functional properties highly similar mouse naive es cells distinct conventional primed human pluripotent cells includes competence generation cross-species chimaeric mouse embryos underwent organogenesis following microinjection human naive ips cells mouse morulas collectively findings establish new avenues regenerative medicine patient-specific ips cell disease modelling study early human development vitro vivo 
